Evidence
Cold Spring Harb Perspect Med. 2024 May 21:a041618. doi: 10.1101/cshperspect.a041618. Online ahead of print.
ABSTRACT
Parkinson’s disease (PD) involves both the central nervous system (CNS) and enteric nervous system (ENS), and their interaction is important for understanding both the clinical manifestations of the disease and the underlying disease pathophysiology. Although the neuroanatomical distribution of pathology strongly suggests that the ENS is involved in disease pathophysiology, there are significant gaps in knowledge about the underlying mechanisms. In this article, we review the clinical presentation and management of gastrointestinal dysfunction in PD. In addition, we discuss the current understanding of disease pathophysiology in the gut, including controversies about early involvement of the gut in disease pathogenesis. We also review current knowledge about gut α-synuclein and the microbiome, discuss experimental models of PD-linked gastrointestinal pathophysiology, and highlight areas for further research. Finally, we discuss opportunities to use the gut-brain axis for the development of biomarkers and disease-modifying treatments.
PMID:38772708 | DOI:10.1101/cshperspect.a041618
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
The Gut-Brain Axis in Parkinson’s Disease
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous System
- Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
- Glial Cell Development and Function in the Zebrafish Central Nervous System
- Regulators of Oligodendrocyte Differentiation
- Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS
- Remote optogenetic control of the enteric nervous system and brain-gut axis in freely-behaving mice enabled by a wireless, battery-free optoelectronic device
- Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies
- The regulation of enteric neuron connectivity by semaphorin 5A is affected by the autism-associated S956G missense mutation
- Schwann Cell Development and Myelination
- The immune system in Parkinson's disease: what we know so far
- Generation of Mammalian Astrocyte Functional Heterogeneity
- Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice
- Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
- The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients
- Oligodendrocytes: Myelination, Plasticity, and Axonal Support
- The Body, the Brain, the Environment, and Parkinson's Disease
- Development of Prefrontal Circuits and Cognitive Abilities
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review
- Central nervous system manifestations following vaccination against COVID-19
- Peripheral neuronal activation shapes the microbiome and alters gut physiology
- Knowns and unknowns of TiLV-associated neuronal disease
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis
- Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders
- The clinical importance of suspected non-Alzheimer disease pathophysiology
- Primary angiitis of the central nervous system
- S100 proteins: a new frontier in fibromyalgia research
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets
- Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease
- Skin-brain axis in Alzheimer's disease - Pathologic, diagnostic, and therapeutic implications: A Hypothetical Review
- Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review
- The vascular contribution of apolipoprotein E to Alzheimer's disease
- Sonic Hedgehog Signalling Pathway Contributes in Age-Related Disorders and Alzheimer's Disease
- Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease
- Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management
- Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke
- Glial plasticity in the zebrafish central nervous system
- Spatial genomics: mapping human steatotic liver disease
- Pathophysiology of cerebral small vessel disease: a journey through recent discoveries
- Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium
- Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium
- The proteomic landscape of microglia in health and disease
- Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes
- Clinical and therapeutic challenges of smouldering multiple sclerosis
- Do microbes play a role in Alzheimer's disease?
- Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis
- The major histocompatibility complex participates in Parkinson's disease
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
- Interaction between central nervous system and immune system after ischemic stroke and its therapeutic significance of traditional Chinese medicine
- Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
- Circadian Biology and the Neurovascular Unit
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
- Label free quantitative proteomic profiling of serum samples of intellectually disabled young patients revealed dysregulation of complement coagulation and cholesterol cascade systems
- Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
- Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
- Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Cross-regulation between the immune system and the extracellular matrix during lung pathology
Evidence Blueprint
The Gut-Brain Axis in Parkinson’s Disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The Gut-Brain Axis in Parkinson’s Disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous System
- Resistance and Resilience to Alzheimer's Disease
- Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
- Glial Cell Development and Function in the Zebrafish Central Nervous System
- Regulators of Oligodendrocyte Differentiation
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS
- Remote optogenetic control of the enteric nervous system and brain-gut axis in freely-behaving mice enabled by a wireless, battery-free optoelectronic device
- The enteric nervous system deficits in autism spectrum disorder
- Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions
- Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies
- Expanded insights into the neural component of the activity-based anorexia animal model - morphological changes in the enteric nervous system and altered pain perception
- The regulation of enteric neuron connectivity by semaphorin 5A is affected by the autism-associated S956G missense mutation
- Schwann Cell Development and Myelination
- The immune system in Parkinson's disease: what we know so far
- Generation of Mammalian Astrocyte Functional Heterogeneity
- Schwann Cells as Orchestrators of Nerve Repair: Implications for Tissue Regeneration and Pathologies
- The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System
- Dedicated macrophages organize and maintain the enteric nervous system
- The gut-brain vascular axis in neuroinflammation
- Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice
- Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease
- The gut microbiota-brain axis in neurological disorder
- Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
- The systemic immune response in Parkinson's disease: focus on the peripheral immune component
- Neuroimmunology of rabies: New insights into an ancient disease
- The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients
- Oligodendrocytes: Myelination, Plasticity, and Axonal Support
- The Body, the Brain, the Environment, and Parkinson's Disease
- Neuropharmacological insights into Gardenia jasminoides Ellis: Harnessing therapeutic potential for central nervous system disorders
- Development of Prefrontal Circuits and Cognitive Abilities
- Neuropathology of Alzheimer's Disease
- The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders
- Optogenetic Vision Restoration
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review
- Blood-brain barrier pathology in cerebral small vessel disease
- Central nervous system manifestations following vaccination against COVID-19
- Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood-onset Systemic Lupus Erythematosus
- Peripheral neuronal activation shapes the microbiome and alters gut physiology
- Knowns and unknowns of TiLV-associated neuronal disease
- GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
- The nervous system and associated disorders
- The nervous system and associated disorders
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
- Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis
- Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders
- An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders
- The clinical importance of suspected non-Alzheimer disease pathophysiology
- Primary angiitis of the central nervous system
- Astrocytes in ischemic stroke: Crosstalk in central nervous system and therapeutic potential
- New Insights into the Roles of p53 in Central Nervous System Diseases
- Boundaries and integration between microbiota, the nervous system, and immunity
- Life-limiting peripheral organ dysfunction in feline Sandhoff disease emerges after effective CNS gene therapy
- S100 proteins: a new frontier in fibromyalgia research
- Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies
- Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease
- How myeloid cells shape experimental autoimmune encephalomyelitis: at the crossroads of outside-in immunity
- Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions
- Pathophysiology of dementia
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- A new conceptual model for anorexia nervosa: A role for connective tissue?
- Data-driven modelling of neurodegenerative disease progression: thinking outside the black box